Table II.

Crude and age-standardized prevalence of hypertension, awareness, treatment and control in WOBASZ II population aged 19–99

Parameter	Age [years]												P-value*
	19–49 (n = 3114)		50–59 (n = 1314)		60–69 (n = 1105)		70–79 (n = 507)		≥ 80 (n = 223)		19–99
	%	95% CI	%	95% CI	%	95% CI	%	95% CI	%	95% CI	Age standardized	95% CI
Prevalence:													0.002
Total	22.1	18.9–25.2	56.8	53.2–60.3	71.5	68.3–74.6	80.3	76.4–84.1	78.0	71.9–84.2	42.7	41.1–44.3
Men	29.6	25.2–34.0	64.1	59.1–69.0	72.3	67.6–76.9	78.0	71.8–84.3	73.2	62.0–84.4	46.2	43.7–48.7
Women	15.6	11.2–20.1	51.3	46.3–56.3	70.9	66.6–75.2	81.9	77.0–86.8	80.9	73.6–88.1	40.4	38.2–42.6
Awareness:													0.0425
Total	45.8	40.2–51.4	70.5	66.6–74.4	77.5	74.2–80.8	80.8	76.6–85.1	82.2	75.9–88.5	59.3	56.0–62.6
Men	45.3	38.1–52.4	67.1	61.2–73.0	71.0	65.4–76.5	71.3	63.1–79.4	71.7	58.2–85.1	55.3	50.9–59.7
Women	46.6	37.6–55.6	73.7	68.6–78.8	82.9	79.0–86.9	87.5	83.0–92.0	87.7	81.3–94.2	63.2	58.1–68.2
Treatment:													< 0.0001
Total	30.2	23.8–36.5	58.2	53.5–62.8	67.0	63.0–71.0	73.2	68.2–78.2	76.4	69.2–83.6	46.1	43.3–48.9
Men	28.6	20.4–36.7	53.6	46.6–60.6	57.2	50.4–63.9	61.1	51.6–70.5	63.3	48.0–78.7	40.2	36.6–43.8
Women	32.8	22.7–42.9	62.5	56.4–68.6	75.2	70.5–79.9	81.7	76.2–87.1	83.3	75.8–90.8	52.1	47.7–56.5
Controlled:													0.133
Total	17.0	10.0–23.9	29.4	23.3–35.4	30.8	25.0–36.6	30.2	22.1–38.3	33	21.2–45.5	23.0	21.0–25.0
Men	15.0	6.1–23.9	23.2	14.2–32.3	25	16.5–34.3	28.3	6.9–49.8	28	6.9–49.8	19.0	16.5–21.6
Women	20.2	9.1–31.2	35.2	27.1–43.2	35	27.7–42.9	33.8	23.5–44.0	36	21.3–50.7	27.3	24.0–30.6

^*Men vs. women.